The clinical research base for the treatment of schizophrenia
Schooler, N.R.; Keith, S.J.
Psychopharmacology Bulletin 29(4): 431-446
1993
ISSN/ISBN: 0048-5764 PMID: 7916158 Document Number: 409105
Document emailed within 1 workday
Related Documents
Riles, S. 1997: New research on the treatment of schizophrenia Nursing Times 93(52): 47Tamminga, C.A. 2001: Introduction: evaluating clinical trial data from schizophrenia research Journal of Clinical Psychiatry 62 Suppl. 9: 3-4
Schooler, N.R.; Keith, S.J.; Severe, J.B.; Matthews, S. 1989: Acute treatment response and short term outcome in schizophrenia: first results of the NIMH treatment strategies in schizophrenia study. Treatment Strategies in Schizophrenia Collaborative Study Group Psychopharmacology Bulletin 25(3): 331-335
Hargreaves, W.A.; Kane, J.M.; Ninan, P.T.; Severe, J.B.; Woerner, M. 1989: Demographic characteristics, treatment history, presenting psychopathology and early course in schizophrenia. Treatment Strategies in Schizophrenia Collaborative Study Group Psychopharmacology Bulletin 25(3): 340-343
Furukori, N. 2010: Clinical pharmacogenetics in the treatment of schizophrenia Nihon Shinkei Seishin Yakurigaku Zasshi 30(2): 65-69
Nakayasu, N.; Seki, Y.; Harima, H. 1999: Age of onset, frequency of the development of symptoms, and treatment outcome in the early stage of schizophrenia--in search of guidelines for early diagnosis and treatment of schizophrenia Seishin Shinkeigaku Zasshi 101(11): 898-907
Damjanović, A.; Ivković, M.; Jasović-Gasić, M.; Paunović, V. 2006: Comorbidity of schizophrenia and cancer: clinical recommendations for treatment Psychiatria Danubina 18(1-2): 55-60
Roca, M.; Cañas, F.; Olivares, J.; Rodríguez, A.; Giner, J. 2007: Treatment adherence in schizophrenia. Spanish clinical consensus Actas Espanolas de Psiquiatria 35(1 Suppl): 1-6
Šagud, M. 2015: Treatment-resistant schizophrenia: challenges and implications for clinical practice Psychiatria Danubina 27(3): 319-326
Kane, J.M. 1992: Clinical efficacy of clozapine in treatment-refractory schizophrenia: an overview British Journal of Psychiatry. Suppl 17: 41-45
Kliushnik, T.P.; Kalinina, M.A.; Sarmanova, Z.V.; Otman, I.N.; Kozlovskaia, G.V. 2009: Dynamics of immunological and clinical parameters in the treatment of childhood schizophrenia Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 109(6): 46-49
Gasparian, T.G. 2007: Skull base chondromas: clinical picture, diagnosis, and treatment Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko 2: 46-48
Das, S.; Barkakaty, B.N.; Roy, R.G.; Pattanayak, S. 1981: Results of treatment with 600 mg. base of chloroquine and 45 mg base of primaquine in P. falciparum in Greater Nicobar and Little Andaman Islands Journal of Communicable Diseases 13(1): 64-66
Wiesel, F.A. 1994: Neuroleptic treatment of patients with schizophrenia. Mechanisms of action and clinical significance British Journal of Psychiatry. Suppl 23: 65-70
Hartmann, W.; Meyer, J.E. 1974: Clinical treatment of chronic schizophrenia in the Federal German Republic. Results and consequences Der Nervenarzt 45(2): 1-8
Cherekaev, V.A.; Korshunov, A.G.; Kornienko, V.N.; Bekiashev, A.K.; Belov, A.I.; Vinokurov, A.G.; Tsikarishvili, V.M.; Kadasheva, A.B.; Smirnov, R.A. 2005: Skull base meningiomas spreading into the infratemporal fossa: clinical picture, diagnosis, and treatment policy Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko 12(4): 6
Glick, I.D.; Jacobs, M.; Lieberman, J.; Simpson, G.; Schooler, N.R. 1989: Prediction of short term outcome in schizophrenia: depressive symptoms, negative symptoms, and extrapyramidal signs. Treatment Strategies in Schizophrenia Collaborative Study Group Psychopharmacology Bulletin 25(3): 344-347
Kringlen, E. 1978: The status of schizophrenia research Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 98(2): 65-69
Munkvad, I. 1977: Biological schizophrenia research Ugeskrift for Laeger 139(45): 2687-2688
Schulsinger, F. 1973: Schizophrenia research--tendencies Ugeskrift for Laeger 135(47): 2576-2577